Kees Bol

Kees Bol is an accomplished executive in clinical pharmacology, currently serving as Executive Director Clinical Pharmacology at Merus N.V., where responsibilities include overseeing all clinical pharmacology aspects of bispecific antibodies in development and leading multidisciplinary Program Development Teams. Previously, Kees held the position of Senior Director Drug Development and CEO of Kinesis Pharma Singapore, where operational, financial, and business development activities for the Singapore office were managed. With extensive experience in early drug development across various therapeutic areas including oncology, HIV/AIDS, and cardiovascular disease, Kees has also worked at Johnson & Johnson as Manager of Clinical Pharmacokinetics and has a strong academic background with a PhD in Pharmacology from Stanford University and an MSc in Biopharmaceutical Sciences from Leiden University.